Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|April 23, 2008
Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypassBruce H Dorman, Robert E Stroud, Michael M Wyckoff, et al.
Circulation. Heart Failure|January 8, 2014
Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overloadMichael R Zile, Catalin F Baicu, Robert E Stroud, et al.
European Journal of Heart Failure|February 1, 2008
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failureAndrew T Yan, Raymond T Yan, Francis G Spinale, et al.
Circulation. Heart Failure|February 26, 2011
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failureMichael R Zile, Stacia M Desantis, Catalin F Baicu, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 27, 2006
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formationJohn R Barbour, Robert E Stroud, Abigail S Lowry, et al.
The Annals of Thoracic Surgery|December 4, 2008
Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activationRachael L Ford, Ira M Mains, Ebony J Hilton, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 27, 2010
Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine modelJeffrey A Jones, Jean Marie Ruddy, Shenikqua Bouges, et al.
Biomolecules|February 27, 2026
Thoracic Aortic Aneurysm Development Is Dependent on Membrane Type-1 Matrix Metalloproteinase Activity and AbundanceYing Xiong, Rupak Mukherjee, Sarah L Lieser, et al.
Pageof 9